FLT3 and acute myeloid leukemia: The combination of AZD5991 and gilterinib or MRX-2843 also synergistically induced apoptosis in the primary AML cells derived from a patient with FLT3-ITD and -TKD AML who failed to achieve remission after induction 3 chemotherapy (Figure 6H).